GUCY1B2
| Official symbol: | GUCY1B2 |
| Full name: | guanylate cyclase 1 soluble subunit beta 2 (pseudogene) |
| Location: | 13q14.3 |
| Also known as: | GC-SB2 |
| Entrez ID: | 2974 |
| Ensembl ID: | ENSG00000123201 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.21 |
|
|
|
| Recurrently deleted in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | Enzyme |
| JensenLab PubMed score: | NA (Percentile rank: NA) |
| PubTator score: | 2.14 (Percentile rank: 17.92%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Predicted TractableTargets with a predicted Ro5 druggable domain (druggable genome); Targets with a drugEBIlity score equal or greater than 0 |
| Tractability (antibody): | |
